Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.56 USD | -1.02% | +3.36% | -44.36% |
15/05 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/03 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- MarketScreener Strategies